Publications by authors named "Maura Dickler"

Claim this Profile
A
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer.
Sarat Chandarlapaty, Maura N Dickler, Jose Alejandro Perez Fidalgo, Rafael Villanueva-Vázquez, Jennifer Giltnane

Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.
Julia C F Quintanilha, Jin Wang, Alexander B Sibley, Wei Xu, Osvaldo Espin-Garcia, Maura N Dickler

Int J Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy.
Mei-Yin C Polley, Maura N Dickler, Jason Sinnwell, Kathleen Tenner, Juan de la Haba

Breast Cancer Res Treat· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
Jeanne Carter, Raymond E Baser, Deborah J Goldfrank, Barbara Seidel, Lisania Milli, Maura N Dickler

Support Care Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer.
Shari B Goldfarb, Volkan Turan, Giuliano Bedoschi, Enes Taylan, Nadia Abdo, Maura N Dickler

Breast Cancer Res Treat· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1.
Hope S Rugo, Veronique Dieras, Javier Cortes, Debra Patt, Hans Wildiers, Maura N Dickler

Breast Cancer Res Treat· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab.
Mark Jesus M Magbanua, Oleksandr Savenkov, Erik J Asmus, Karla V Ballman, Janet H Scott, Maura Dickler

Clin Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.
Kutluk H Oktay, Giuliano Bedoschi, Shari B Goldfarb, Enes Taylan, Shiny Titus, Maura N Dickler

Fertil Steril· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in and promote clinical resistance to alpelisib plus aromatase inhibitors.
Pedram Razavi, Maura N Dickler, Payal D Shah, Weiyi Toy, David N Brown

Nat Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials.
Hala Makhlouf, Mark A Watson, Heather A Lankes, Carol Weil, Maura Dickler

Am J Clin Pathol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors.
Neil Vasan, Pedram Razavi, Jared L Johnson, Hong Shao, Hardik Shah, Maura N Dickler

Science· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifocal/Multicentric Ipsilateral Invasive Breast Carcinomas with Similar Histology: Is Multigene Testing of All Individual Foci Necessary?
Anne Grabenstetter, Edi Brogi, Joanne F Chou, Monica Morrow, Maura Dickler

Ann Surg Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials.
Yingbing Wang, Karen L Ayres, Debra A Goldman, Maura N Dickler, Aditya Bardia

Clin Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "Multicentric Ipsilateral Invasive Breast Carcinomas Might Have Higher 21-Gene Recurrence Score Compared with Multifocal Ipsilateral Invasive Breast Carcinomas".
Anne Grabenstetter, Edi Brogi, Joanne Chou, Monica Morrow, Maura Dickler

Ann Surg Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rigorous evaluation of an institutionally-based communication skills program for post-graduate oncology trainees.
Carma L Bylund, Smita C Banerjee, Philip A Bialer, Ruth Manna, Tomer T Levin, Maura Dickler

Patient Educ Couns· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
Patrick G Morris, Selene Rota, Karen Cadoo, Stephen Zamora, Sujata Patil, Maura Dickler

Clin Breast Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study.
Daneng Li, Linda M McCall, Olwen M Hahn, Clifford A Hudis, Harvey J Cohen, Maura N Dickler

Breast Cancer Res Treat· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer.
Maura N Dickler, Cristina Saura, Donald A Richards, Ian E Krop, Andrés Cervantes

Clin Cancer Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
Ting Bao, Andrew D Seidman, Lauren Piulson, Emily Vertosick, Xi Chen, Maura N Dickler

Eur J Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.
Pedram Razavi, Matthew T Chang, Guotai Xu, Chaitanya Bandlamudi, Dara S Ross, Maura N Dickler

Cancer Cell· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 21-Gene Recurrence Score in Male Breast Cancer.
Gulisa Turashvili, Monica Gonzalez-Loperena, Edi Brogi, Maura Dickler, Larry Norton

Ann Surg Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial.
Jessica M Scott, Neil M Iyengar, Tormod S Nilsen, Meghan Michalski, Samantha M Thomas, Maura N Dickler

Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen Receptor-Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance.
Adam M Brufsky, Maura N Dickler

Oncologist· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint Inhibitors in the Treatment of Breast Cancer.
Tomas G Lyons, Maura N Dickler, Elizabeth E Comen

Curr Oncol Rep· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended Adjuvant Aromatase Inhibitor Therapy in Post-Menopausal Women.
Stephen M Schleicher, Maura N Dickler

Curr Breast Cancer Rep· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis